iRhythm Technologies, maker of the Zio patch peel-and-stick heart monitor, has raised $17 million in a round led by Novo A/S, a Danish life sciences investment firm. Previous investor Norwest Venture ...

Aetna will now reimburse for iRhythm's ZIO Patch, a continuous long-term heart monitor worn on an adhesive patch. The insurer recently updated its Clinical Policy Bulletin on cardiac event monitors, ...

Heart disease, particularly conditions like atrial fibrillation (AFib), is a leading cause of death worldwide, and traditional cardiac monitoring methods often present challenges in patient comfort ...

The MarketWatch News Department was not involved in the creation of this content. New single-lead patch strengthens the company's advanced ECG monitoring platform. BOSTON, Aug. 5, 2025 ...

The market has left medical device stocks in the dust, but heart monitor maker iRhythm Technologies is proving an exception. As doctors and hospitals slap its Zio patch monitors on more patients, the ...

iRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S. The new Zio monitor is a prescription-only ECG monitor, which is an integral part of the Zio LTCM service. The ...